Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05112601 |
| Consolidated Lead Sponsor | National Cancer Institute (NCI) |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 81 participants (ESTIMATED) |
| Registered Start Date | 2022-06-02 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University of Alabama at Birmingham Cancer Center | Birmingham, AL | Open Hospital Dossier -> |
| Augusta University Medical Center | Augusta, GA | Open Hospital Dossier -> |
| Saint Alphonsus Cancer Care Center-Boise | Boise, ID | Open Hospital Dossier -> |
| Saint Luke's Cancer Institute - Boise | Boise, ID | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.